Vermont Center for Immunology and Infectious Diseases ~ 2013 Annual Report
Ralph Budd, M.D., Director
The Vermont Center for Immunology and Infectious Diseases (VCIID) studies the host response to infections. It is currently in the seventh year of funding from a National Institutes of Health Center of Biomedical Research Excellence (COBRE) grant, and now has 24 faculty embers spanning eight departments in four colleges at UVM.
A significant achievement for the VCIID this
year was the groundbreaking of a new Vermont
Department of Health/UVM research building
at the Colchester Research Facility that will
house investigators from both institutions. This
will combine the complementary expertise of
Department of Health staff in epidemiology and
field research in infectious diseases with those
of UVM faculty in basic and clinical microbiology
and immunology. This partnership exists in
only a couple of other states, and will benefit
the health of all Vermonters.
Accomplishments of individual faculty include the study by Jane Hill, Ph.D., focused on detecting bacterial pathogens in lung infections in exhaled breath using mass spectrometry, which was publicized wisely, including coverage by the British Broadcasting Corporation. Christopher Huston, M.D., received a new R21 award from the NIH/National Institute of Allergy and Infectious Diseases to study “Novel approaches to develop a treatment for cryptosporidiosis.” Aimee Shen, Ph.D., was named the “Pew Scholar of the Month” in July 2013. Mercedes Rincon, Ph.D., was the organizing editor for a review on Interleukin-6 that appeared in the International Journal of Biomedical Science.
The UVM Vaccine Testing Center, under the direction of Beth Kirkpatrick, M.D., began an important clinical trial of an oral cholera vaccine.
This year, other faculty associated with the center published research in such journals as PLOS One, Journal of Immunology, Mucosal Immunology, American Journal of Pathology, PLOS Neglected Tropical Diseases, and the Journal of Bacteriology.
Last modified January 02 2014 09:05 AM